EUVIMEDEUVIMED entdecken
Crossref

Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis

Peng Lyu, Fengyue Li, Runzhi Deng, Qiliang Wei, Bingkai Lin, Lei Cheng, Bixing Zhao, Zhonglei Lu

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024

DOI: 10.1016/j.bbadis.2024.167233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Peng Lyu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, PR China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Glycogen Synthase Kinase 3 beta, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Fujian Provincial Department of Education, Fujian Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) poses a significant threat due to its highly aggressive and high recurrence characteristics, necessitating urgent advances in diagnostic and therapeutic approaches. Long non-coding RNAs exert vital roles in HCC tumorigenesis, however the mechanisms of their expression regulation and functions are not fully elucidated yet. Herein, we identify that a novel tumor suppressor 'lnc-PIK3R1' was significantly downregulated in HCC tissues, which was correlated with poor prognosis. Functionally, lnc-PIK3R1 played tumor suppressor roles to inhibit the proliferation and mobility of HCC cells, and to impede the distant implantation of xenograft in mice. Mechanistic studies revealed that lnc-PIK3R1 interacted with miR-1286 and alleviated the repression on GSK3B by miR-1286. Notably, pharmacological inhibition of GSK3β compromised the tumor suppression effect by lnc-PIK3R1, confirming their functional relevance. Moreover, we identified that oncogenic YY1 acts as a specific transcriptional repressor to downregulate the expression of lnc-PIK3R1 in HCC. In summary, this study highlights the tumor-suppressive effect of lnc-PIK3R1, and provides new insights into the regulation of GSK3β expression in HCC, which would benefit the development of innovative intervention strategies for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGlycogen Synthase Kinase 3 betaMicroRNAsRNA, Long NoncodingYY1 Transcription FactorGene Expression Regulation, NeoplasticClass Ia Phosphatidylinositol 3-KinaseHumansAnimalsMiceDisease ProgressionCell ProliferationCell Line, TumorMaleMice, NudeFemale

Stichwörter der Autor:innen

GSK3βHepatocellular carcinoma (HCC)Lnc-PIK3R1miR-1286

Substanzen

Glycogen Synthase Kinase 3 betaMicroRNAsRNA, Long NoncodingYY1 Transcription FactorGSK3B protein, humanPIK3R1 protein, humanClass Ia Phosphatidylinositol 3-KinaseYY1 protein, human

Autor:innen und Institutionen

  • College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, PR China.
  • The United Innovation of Mengchao Hepatobiliary Technology, Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China. Electronic address: bixingzhao@gmail.…
  • College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, PR China. Electronic address: zhonglei.lu@fzu.edu.cn.

Förderung

  • Fujian Provincial Department of Education
  • Fujian Provincial Natural Science Foundation
  • National Natural Science Foundation of China
  • Fuzhou University

Zitieren

APA

Lyu, P., Li, F., Deng, R., Wei, Q., Lin, B., Cheng, L., Zhao, B., & Lu, Z. (2024). Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167233

Vancouver

Lyu P, Li F, Deng R, Wei Q, Lin B, Cheng L, et al. Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167233

BibTeX
@article{Lyu2024,
  author = {Lyu, Peng and Li, Fengyue and Deng, Runzhi and Wei, Qiliang and Lin, Bingkai and Cheng, Lei and Zhao, Bixing and Lu, Zhonglei},
  title = {Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2024},
  doi = {10.1016/j.bbadis.2024.167233}
}
Kostenlos starten →